Medicamen Biotech Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 43.13 | 42.06 | 45.55 |
| Operating Expense | 36.30 | 36.62 | 38.19 |
| Net Profit | 2.27 | 2.26 | 3.10 |
| Net Profit Margin | 5.26 | 5.37 | 6.81 |
| Earning Per Share | 1.78 | 1.78 | 2.45 |
| EBIDTA | 6.90 | 5.52 | 7.53 |
| Effective Tax Rate | 15.35 | 15.44 | 10.72 |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 43.13 |
| Operating Expense | 36.30 |
| Net Profit | 2.27 |
| Net Profit Margin | 5.26 |
| Earning Per Share | 1.78 |
| EBIDTA | 6.90 |
| Effective Tax Rate | 15.35 |
Invest in Medicamen Biotech Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 172.39 | 137.88 | 115.45 |
| Operating Expenses Annual | 146.42 | 113.74 | 91.89 |
| Operating Profit Annual | 28.27 | 26.61 | 25.28 |
| Interest Annual | 4.38 | 2.92 | 1.40 |
| Depreciation | 6.83 | 6.24 | 5.67 |
| Net Profit Annual | 13.30 | 15.00 | 14.91 |
| Tax Annual | 3.59 | 2.33 | 3.20 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 172.39 |
| Operating Expenses Annual | 146.42 |
| Operating Profit Annual | 28.27 |
| Interest Annual | 4.38 |
| Depreciation | 6.83 |
| Net Profit Annual | 13.30 |
| Tax Annual | 3.59 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 20.44 | 3.81 | 3.08 |
| Cash Flow from Operations | -0.25 | -3.50 | 4.81 |
| Cash Flow from Investing | -8.71 | -7.54 | -8.47 |
| Cash Flow from Financing | 3.14 | 27.67 | 4.39 |
| Cash Flow at the End | 14.62 | 20.44 | 3.81 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 20.44 |
| Cash Flow from Operations | -0.25 |
| Cash Flow from Investing | -8.71 |
| Cash Flow from Financing | 3.14 |
| Cash Flow at the End | 14.62 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 17.14 | 19.64 | 22.36 |
| PBIT Margin (%) | 13.08 | 15.03 | 17.37 |
| PBT Margin (%) | 10.77 | 10.60 | 8.41 |
| Net PROFIT Margin (%) | 7.72 | 10.88 | 12.91 |
| Return On Networth / Equity (%) | 6.60 | 8.78 | 10.56 |
| Return On Networth /Employed (%) | 9.76 | 10.45 | 12.17 |
| Return On Assets (%) | 5.79 | 7.62 | 9.04 |
| Total Debt / Equity (X) | 0.14 | 0.15 | 0.16 |
| Asset Turnover Ratio (%) | 0.75 | 0.70 | 0.70 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 17.14 |
| PBIT Margin (%) | 13.08 |
| PBT Margin (%) | 10.77 |
| Net PROFIT Margin (%) | 7.72 |
| Return On Networth / Equity (%) | 6.60 |
| Return On Networth /Employed (%) | 9.76 |
| Return On Assets (%) | 5.79 |
| Total Debt / Equity (X) | 0.14 |
| Asset Turnover Ratio (%) | 0.75 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 91.10 | 92.36 | 92.48 |
| Total Current Assets Annual | 152.37 | 157.97 | 120.98 |
| Non Current Assets Annual | 141.84 | 118.81 | 104.72 |
| Total Shareholders Funds Annual | 209.21 | 193.80 | 148.04 |
| Total Assets Annual | 294.21 | 276.78 | 225.70 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 91.10 |
| Total Current Assets Annual | 152.37 |
| Non Current Assets Annual | 141.84 |
| Total Shareholders Funds Annual | 209.21 |
| Total Assets Annual | 294.21 |
EPS (INR)
Expected
1.15
Reported
0.71
Surprise
-38.26%
Jun 2024
EPS beaten by -38.26%
Mar 2024
EPS beaten by -40.57%
Dec 2023
EPS beaten by -4.17%
